The LightPathTM Imaging System helps surgeons to precisely locate cancer cells, ensuring diseased tissue can be cleared in a single operation. It is the first commercially available imaging device with this capability. The product was developed in collaboration with R&D specialist Sagentia.
LightPath integrates the latest imaging technology with a mobile device suitable for use in busy operating rooms.
Alistair Fleming, Head of Surgical and Diagnostics at Sagentia, says: “The system detects Cerenkov Luminescence, a subtle light produced by PET imaging agents widely used in cancer diagnosis. The light is so faint that it is like trying to see a candle from 40 miles away, presenting significant challenges.”
LightPath is commercially available in Europe.